Axogen (LTS:0HKD) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 01, 2026)


LTS:0HKD Axogen Inc LTS:0HKD
62 GF Score
Price $44.84
GF Value $15.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Axogen Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Axogen's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

LTS:0HKD vs TMDX, BFLY, ESTA: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Axogen's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Axogen Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Axogen's Margin of Safety % (DCF FCF Based) falls into.


LTS:0HKD
62GF Score
Axogen Inc LTS:0HKD
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Axogen (LTS:0HKD) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of $44.84 is trading 196.4% above its estimated GF Value™ of $15.13. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for LTS:0HKD:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $15.13 vs. price of $44.84 (196.4% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the LTS:0HKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Other Exchanges AXGN:USALT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
62GF Score

Get the complete analysis for LTS:0HKD

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$44.84
Price
$15.13
GF Value